Resultados da pesquisa por Autor

1

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age

Por Jackson, Robert L, Hunt, Barbara, MacDonald, Patricia A
Publicado em 2012

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

African American patients with gout: efficacy and safety of febuxostat vs allopurinol

African American patients with gout: efficacy and safety of febuxostat vs allopurinol

Por Wells Alvin F, MacDonald Patricia A, Chefo Solomon, Jackson Robert L
Publicado em 2012-02-01

Obter o texto integral

Artigo

3

African American patients with gout: efficacy and safety of febuxostat vs allopurinol

African American patients with gout: efficacy and safety of febuxostat vs allopurinol

Por Wells, Alvin F, MacDonald, Patricia A, Chefo, Solomon, Jackson, Robert L
Publicado em 2012

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

Making good on a call to expand method choice for young people - Turning rhetoric into reality for addressing Sustainable Development Goal Three

Making good on a call to expand method choice for young people - Turning rhetoric into reality for addressing Sustainable Development Goal Three

Por Fikree, Fariyal Fatma, Lane, Catharine, Simon, Callie, Hainsworth, Gwyn, MacDonald, Patricia
Publicado no Reprod Health (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones

Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones

Por Goldfarb, David S., MacDonald, Patricia A., Gunawardhana, Lhanoo, Chefo, Solomon, McLean, Lachy
Publicado em 2013

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Por Becker, Michael A, Schumacher, H Ralph, Espinoza, Luis R, Wells, Alvin F, MacDonald, Patricia, Lloyd, Eric, Lademacher, Christopher
Publicado em 2010

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Serum Urate in Chronic Gout — Will It Be the First Validated Soluble Biomarker in Rheumatology?

Serum Urate in Chronic Gout — Will It Be the First Validated Soluble Biomarker in Rheumatology?

Por STAMP, LISA K., KHANNA, PUJA P., DALBETH, NICOLA, BOERS, MAARTEN, MAKSYMOWYCH, WALTER P., SCHUMACHER, H. RALPH, BECKER, MICHAEL A., MacDONALD, PATRICIA A., EDWARDS, N. LAWRENCE, SINGH, JASVINDER A., SIMON, LEE S., McQUEEN, FIONA M., NEOGI, TUHINA, GAFFO, ANGELO L., STRAND, VIBEKE, TAYLOR, WILLIAM J.
Publicado em 2011

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

Patient-reported Outcomes in Chronic Gout: A Report from OMERACT 10

Patient-reported Outcomes in Chronic Gout: A Report from OMERACT 10

Por SINGH, JASVINDER A., TAYLOR, WILL J., SIMON, LEE S., KHANNA, PUJA P., STAMP, LISA K., McQUEEN, FIONA M., NEOGI, TUHINA, GAFFO, ANGELO L., BECKER, MICHAEL A., MacDONALD, PATRICIA A., DABBOUS, OMAR, STRAND, VIBEKE, DALBETH, NICOLA D., ALETAHA, DANIEL, EDWARDS, N. LAWRENCE, SCHUMACHER, H. RALPH
Publicado em 2011

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo